about
The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membraneFunctional domains of the human epididymal protease inhibitor, eppinWdnm1-like, a new adipokine with a role in MMP-2 activationWFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infectionPotential prognostic, diagnostic and therapeutic markers for human gastric cancerAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsWFDC1 is a key modulator of inflammatory and wound repair responsesTowards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studiesSystematic analysis of secreted proteins reveals synergism between IL6 and other proteins in soft agar growth of MCF10A cellsA mouse to human search for plasma proteome changes associated with pancreatic tumor development.The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.The biology of ovarian cancer: new opportunities for translationOverexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.Age and diet affect gene expression profiles in canine liver tissue.The mouth: a gateway or a trap for HIV?WAP four-disulfide core domain protein 2 promotes metastasis of human ovarian cancer by regulation of metastasis-associated genesDeep sequencing reveals distinct patterns of DNA methylation in prostate cancer.Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma.HE4 as a biomarker for ovarian and endometrial cancer management.HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinomaSerum HE4: An Independent Prognostic Factor in Non-Small Cell Lung CancerOptimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosisIL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesisWAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cellsA novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massExpression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.Reproduction and immunity-driven natural selection in the human WFDC locus.HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell LinesPAX2 Expression in Ovarian Cancer.Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer.Modulated expression of WFDC1 during carcinogenesis and cellular senescenceOverexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.Secretory leukocyte peptidase inhibitor and lung cancer.Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.Molecular signatures of ovarian cancer: from detection to prognosis.
P2860
Q21143809-136B9DFE-97B1-4892-BDFE-C0ADBAB87673Q24309156-74546350-D693-4665-84EE-51715F2152AAQ24314696-DC713B1A-2C33-4317-9378-1036B544623CQ24657262-A4AAD35D-5DC5-4F80-9B0F-7B15FA60983FQ26866200-5C80C09E-D03B-4762-AA94-2D5E8470CBB2Q28087327-5D82FE4F-07FE-4F07-9BA5-9CA25956844CQ28505746-52FD623F-63AB-4C2D-83A1-509DCB6A6477Q30414041-227A0BCF-E83B-4ECF-8219-83B71364AF5FQ31021549-1D69B137-BC38-4D3F-B039-1EE77F173F41Q33343004-A5DC1529-19A2-495E-B520-67B623BACFA7Q33572029-7A67BA08-860D-4543-9BA9-750BE39018F2Q33622369-861960C5-FD7B-44DF-B161-20F1EAD47CFCQ33622587-781C1A66-4012-47E9-8D53-DF7F327FB505Q33725680-46F5D8E6-590C-4843-BD31-991768F1D2B8Q33874252-89BAE416-DD3B-4875-B1BE-C4C662C20388Q33876850-B7583CB0-CBA0-49F5-BD31-5CAB66C08E7AQ33949373-6AB75DA3-592D-4F01-BCFA-1BC66E2826D7Q33955266-BD2798C7-AF5A-41AE-A71D-9D56B4C133FCQ34181948-89E7C8EA-7C73-433B-BBE5-4149FE0D18E9Q34611530-1A8BD2D0-9262-4D77-ACF5-B100DCC0FCF9Q34621826-BB825CB9-FA5C-4215-ADC6-C168DA07C5FEQ34695596-721B9E50-E031-4251-836B-774C3D55101AQ35071264-655A41D0-DBA0-4161-BD73-0E17BABC2FBEQ35648196-965B7325-5FF1-4B04-A353-D5483DB1B367Q35837949-D81C66E1-F423-41C8-B995-F35CD276832BQ35981299-2C6DD535-B7E3-4B98-BF32-5A1312D8D375Q36193541-0633522C-B2E4-48F8-B20B-C44B9198EA94Q36629304-10FC3EA6-EF49-4A5E-A481-E31D6633DD72Q36673988-39E1DBB2-AA62-46CD-8CB4-2C648795CAE3Q36674118-DAB18B0C-6423-4AE0-ADFB-665F76E12237Q36702004-A1EF4D82-CBD3-442D-AF76-B7629DEB929FQ36790307-D049CDA1-F4C3-45A5-9ED6-239531986297Q36790325-87069893-271E-4612-B4F2-0FED2F75DB80Q36954678-680F91FB-8617-471C-B377-5015E8541AD2Q37090422-7AB691A5-D548-429F-908D-D25B9B63438AQ37114356-B981669D-4672-4B19-8F13-3CE3B7C37474Q37124951-26CC422F-503B-4C7A-86B0-45AAC1B6CEB8Q37553857-81D977D6-E4EB-47CC-AC1C-8EF008788DE5Q37655098-C3182456-79F8-4FBE-9BAB-E1A746BE82A3Q37685074-0F2A87E0-1F43-4E38-B186-046ED5BCC399
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Proteins with whey-acidic-protein motifs and cancer
@ast
Proteins with whey-acidic-protein motifs and cancer
@en
Proteins with whey-acidic-protein motifs and cancer
@nl
type
label
Proteins with whey-acidic-protein motifs and cancer
@ast
Proteins with whey-acidic-protein motifs and cancer
@en
Proteins with whey-acidic-protein motifs and cancer
@nl
prefLabel
Proteins with whey-acidic-protein motifs and cancer
@ast
Proteins with whey-acidic-protein motifs and cancer
@en
Proteins with whey-acidic-protein motifs and cancer
@nl
P2093
P3181
P1433
P1476
Proteins with whey-acidic-protein motifs and cancer
@en
P2093
Dany Morisset
Dominique Bouchard
Guy M Tremblay
Yves Bourbonnais
P304
P3181
P356
10.1016/S1470-2045(06)70579-4
P407
P577
2006-02-01T00:00:00Z